Table 2.
Comparison of KCCQ Score Between Treatment Groups
Telemonitoring | Usual Care | Total | ||
---|---|---|---|---|
(n =756) | (n=765) | (N=1521) | P value | |
KCCQ Overall Summary Score– mean±s.d. | ||||
Baseline | 60.7 ± 24.1 | 58.6 ± 24.9 | 59.6 ± 24.5 | 0.11 |
3-months | 69.9 ± 24.5 | 67. 9 ± 25.8 | 68.9 ± 25.2 | 0.15 |
6-months | 72.3 ± 24.4 | 68.5 ± 26.4 | 70.4 ± 25.5 | 0.01 |
KCCQ Physical Limitations– mean±s.d. | ||||
Baseline | 69.6 ± 27.8 | 68.7 ± 28.5 | 69.1 ± 28.2 | 0.55 |
3-months | 75.8 ± 27.3 | 75.1 ± 27.2 | 75.5 ± 27.2 | 0.70 |
6-months | 77.1 ± 26.1 | 74.9 ± 27.9 | 76.0 ± 27.0 | 0.18 |
KCCQ Total Symptom Score– mean±s.d. | ||||
Baseline | 64.2 ± 26.7 | 60.6 ± 28.4 | 62.4 ± 27.6 | 0.02 |
3-months | 72.2 ± 26.3 | 69.4 ± 27.6 | 70.9 ± 27.0 | 0.07 |
6-months | 74.0 ± 26.0 | 69.6 ± 28.9 | 71.8 ± 27.5 | 0.007 |
KCCQ Self-Efficacy– mean±s.d. | ||||
Baseline | 83.1 ± 20.9 | 82.9 ± 20.3 | 83.0 ± 20.6 | 0.88 |
3-months | 86.2 ± 18.8 | 87.1 ± 17.5 | 86.6 ± 18.2 | 0.39 |
6-months | 88.5 ± 18.1 | 87.1 ± 17.8 | 87.8 ± 18.0 | 0.23 |
KCCQ Quality of Life– mean±s.d. | ||||
Baseline | 54.4 ± 26.9 | 53.8 ± 27.3 | 54.1 ± 27.1 | 0.65 |
3-months | 66.2 ± 28.0 | 64.5 ± 28.8 | 65.4 ± 28.4 | 0.32 |
6-months | 68.7 ± 27.1 | 65.2 ± 29.4 | 67.0 ± 28.3 | 0.04 |
KCCQ Social Limitations – mean±s.d. | ||||
Baseline | 56.6 ± 33.2 | 53.0 ± 33.0 | 54.8 ± 33.1 | 0.06 |
3-months | 66.4 ± 31.2 | 65.4 ± 32.8 | 65.9 ± 32.0 | 0.61 |
6-months | 69.7 ± 31.3 | 66.6 ± 32.1 | 68.1 ± 31.7 | 0.12 |
Abbreviations: KCCQ, Kansas City Cardiomyopathy Questionnaire; s.d., standard deviation